214 related articles for article (PubMed ID: 26083525)
1. The Effect of Renin-Angiotensin-Aldosterone System Blockade Medications on Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography: A Meta-Analysis.
Wu Z; Zhang H; Jin W; Liu Y; Lu L; Chen Q; Zhang R
PLoS One; 2015; 10(6):e0129747. PubMed ID: 26083525
[TBL] [Abstract][Full Text] [Related]
2. Renin-angiotensin-aldosterone system blockade is associated with higher risk of contrast-induced acute kidney injury in patients with diabetes.
Ma M; Wan X; Gao M; Pan B; Chen D; Sun Q; Zhang M; Zhou C; Li T; Pan H; Shao W; Liu Z; Chen Y; Cao C
Aging (Albany NY); 2020 Apr; 12(7):5858-5877. PubMed ID: 32241961
[TBL] [Abstract][Full Text] [Related]
3. Impact of RAAS Blockers on Contrast-Induced Nephropathy in Patients With Renal Insufficiency: A Meta-Analysis.
Huang Y; Zhang S; Liu M; Zhong X; Lin Y; Xiong Z; Fan Y; Zhou H; Sun X; Guo Y; Xu X; Li Y; Yang D; Zhuang X; Liao X
J Cardiovasc Pharmacol; 2020 Dec; 76(6):692-697. PubMed ID: 32889964
[TBL] [Abstract][Full Text] [Related]
4. Effect of renin-angiotensin system blockers on contrast-induced acute kidney injury in patients with normal or mild-to-moderate reduced kidney function undergoing coronary angiography: A systematic review and meta-analysis.
Yamada T; Fujisaki T; Chopra N; Yamaji T; Azushima K; Kobayashi R; Kinguchi S; Urate S; Suzuki T; Abe E; Wakui H; Tamura K; Steinberg D
Clin Nephrol; 2020 Nov; 94(5):227-236. PubMed ID: 32870151
[TBL] [Abstract][Full Text] [Related]
5. The effects of chronic usage of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on contrast-induced nephropathy in low-risk patients [corrected].
Barış N; Özpelit E; Doğan NB; Kangül H; Gül S; Akdeniz B; Güneri S
Anadolu Kardiyol Derg; 2013 May; 13(3):245-50. PubMed ID: 23261803
[TBL] [Abstract][Full Text] [Related]
6. Intensity of hydration changes the role of renin-angiotensin-aldosterone system blockers in contrast-induced nephropathy risk after coronary catheterisation in patients with chronic kidney disease.
Guo XS; Wu DX; Bei WJ; Li HL; Wang K; Zhou YL; Duan CY; Chen SQ; Lian D; Li LW; Liu Y; Tan N; Chen JY
J Renin Angiotensin Aldosterone Syst; 2017; 18(2):1470320317708894. PubMed ID: 28490226
[TBL] [Abstract][Full Text] [Related]
7. Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction.
Martin N; Manoharan K; Davies C; Lumbers RT
Cochrane Database Syst Rev; 2021 May; 5(5):CD012721. PubMed ID: 34022072
[TBL] [Abstract][Full Text] [Related]
8. Effects of angiotensin converting enzyme inhibitors and angiotensin receptor blockers in contrast-induced nephropathy.
Zhou L; Duan S
Kidney Blood Press Res; 2013; 38(2-3):165-71. PubMed ID: 24686005
[TBL] [Abstract][Full Text] [Related]
9. Impact of renin-angiotensin-aldosterone system-blocking agents on the risk of contrast-induced acute kidney injury: a prospective study and meta-analysis.
Peng F; Su J; Lin J; Niu W
J Cardiovasc Pharmacol; 2015 Mar; 65(3):262-8. PubMed ID: 25502308
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for preserving residual kidney function in peritoneal dialysis patients.
Zhang L; Zeng X; Fu P; Wu HM
Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD009120. PubMed ID: 24953826
[TBL] [Abstract][Full Text] [Related]
11. Association Between Renin-Angiotensin-Aldosterone System Inhibitors and Clinical Outcomes in Patients With COVID-19: A Systematic Review and Meta-analysis.
Baral R; Tsampasian V; Debski M; Moran B; Garg P; Clark A; Vassiliou VS
JAMA Netw Open; 2021 Mar; 4(3):e213594. PubMed ID: 33787911
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis of effect of renin-angiotensin-aldosterone system blockers on contrast-induced nephropathy.
Wang W; Qu W; Sun D; Liu X
J Renin Angiotensin Aldosterone Syst; 2020; 21(2):1470320320919587. PubMed ID: 32370685
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.
Sharma P; Blackburn RC; Parke CL; McCullough K; Marks A; Black C
Cochrane Database Syst Rev; 2011 Oct; (10):CD007751. PubMed ID: 21975774
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin Receptor Blockers as an Alternative to Angiotensin-Converting Enzyme Inhibitors in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention.
Lim S; Choo EH; Choi IJ; Ihm SH; Kim HY; Ahn Y; Chang K; Jeong MH; Seung KB
J Korean Med Sci; 2019 Nov; 34(45):e289. PubMed ID: 31760711
[TBL] [Abstract][Full Text] [Related]
15. The effect of withdrawal of ACE inhibitors or angiotensin receptor blockers prior to coronary angiography on the incidence of contrast-induced nephropathy.
Rosenstock JL; Bruno R; Kim JK; Lubarsky L; Schaller R; Panagopoulos G; DeVita MV; Michelis MF
Int Urol Nephrol; 2008; 40(3):749-55. PubMed ID: 18438718
[TBL] [Abstract][Full Text] [Related]
16. Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progression of chronic kidney disease.
Chung EY; Ruospo M; Natale P; Bolignano D; Navaneethan SD; Palmer SC; Strippoli GF
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD007004. PubMed ID: 33107592
[TBL] [Abstract][Full Text] [Related]
17. The effect of renin-angiotensin-aldosterone system blockade on contrast-induced acute kidney injury: a propensity-matched study.
Rim MY; Ro H; Kang WC; Kim AJ; Park H; Chang JH; Lee HH; Chung W; Jung JY
Am J Kidney Dis; 2012 Oct; 60(4):576-82. PubMed ID: 22658321
[TBL] [Abstract][Full Text] [Related]
18. ACE Inhibitor Benefit to Kidney and Cardiovascular Outcomes for Patients with Non-Dialysis Chronic Kidney Disease Stages 3-5: A Network Meta-Analysis of Randomised Clinical Trials.
Zhang Y; He D; Zhang W; Xing Y; Guo Y; Wang F; Jia J; Yan T; Liu Y; Lin S
Drugs; 2020 Jun; 80(8):797-811. PubMed ID: 32333236
[TBL] [Abstract][Full Text] [Related]
19. Effect of calcium channels blockers and inhibitors of the renin-angiotensin system on renal outcomes and mortality in patients suffering from chronic kidney disease: systematic review and meta-analysis.
Zhao HJ; Li Y; Liu SM; Sun XG; Li M; Hao Y; Cui LQ; Wang AH
Ren Fail; 2016 Jul; 38(6):849-56. PubMed ID: 27055479
[TBL] [Abstract][Full Text] [Related]
20. Effects of withdrawing vs continuing renin-angiotensin blockers on incidence of acute kidney injury in patients with renal insufficiency undergoing cardiac catheterization: Results from the Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker and Contrast Induced Nephropathy in Patients Receiving Cardiac Catheterization (CAPTAIN) trial.
Bainey KR; Rahim S; Etherington K; Rokoss ML; Natarajan MK; Velianou JL; Brons S; Mehta SR;
Am Heart J; 2015 Jul; 170(1):110-6. PubMed ID: 26093871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
